YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
3 Cash-Producing Stocks We Steer Clear Of Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunitie…
3 Reasons to Avoid GDRX and 1 Stock to Buy Instead What a fantastic six months it's been for GoodRx. Shares of the company have skyrocketed 58.7%, hitting $3.29. This was partly thanks to its solid quarterly results, and the run-up might h…
FedEx Corporation (NYSE:FDX) closed at $290.36 on October 2, and United Parcel Service, Inc. (NYSE:UPS) at $93.02. Two companies move parcels around the same world for broadly the same customers. Over the past twelve months, one of them ga…
Amazon.com, Inc. (NASDAQ:AMZN) and GoodRx Holdings, Inc. (NASDAQ:GDRX) are signing up Americans for flat-fee prescription plans as health insurance coverage thins, according to a Reuters report on September 29. Amazon charges from $5 a mon…
1 Value Stock to Target This Week and 2 That Underwhelm Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they're out of favor. The key risk, however, is that…
3 of Wall Street's Favorite Stocks We Approach with Caution Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analysts rare…
New $24.99 monthly plan includes a primary member and up to four dependents, including children, adults, and pets, with more than 250 generic medications available for free and savings on dental, vision, lab and imaging services Brief Summ…
1 Momentum Stock with Exciting Potential and 2 That Underwhelm The stocks featured in this article are seeing some big returns. Over the past month, they've outpaced the market due to some combination of positive news, upbeat results, or s…
Unpacking Q2 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Hims…
Hims & Hers Health HIMS stock has surged 105.4% over the past six months, dramatically outperforming the healthcare industry and the S&P 500's growth of 45.8% and 12.5%, respectively. Second-quarter revenues jumped nearly 40% year over yea…
Reflecting On Healthcare Technology Stocks' Q2 Earnings: GoodRx (NASDAQ:GDRX) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at GoodRx (NASDAQ:GDRX) and its peer…
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. GoodRx Holdings has delivered a steep 89.7% share price decline over the past five years. The sto…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. GoodRx Holdings (GDRX) is back in focus after its Q2 2026 earnings…
Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales fell by 1.3% year on year to $200.4 million. The company's full-year revenue guidance of $797.5 million at the m…
Hims & Hers Health Earnings: What To Look For From HIMS Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here's what to expect. Hims & Hers Health missed analysts' revenu…
GoodRx (GDRX) CEO & president Wendy Barnes joins Josh Lipton on Market Domination to discuss the company's strategy to expand beyond prescription savings. Highlighting strong growth across the business, with subscription revenue up 39% and…
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these business…
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items. A qu…
For the quarter ended June 2026, GoodRx Holdings, Inc. (GDRX) reported revenue of $200.41 million, down 1.3% over the same period last year. EPS came in at $0.08, compared to $0.09 in the year-ago quarter. The reported revenue represents a…
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results exceeding the market's revenue expectations , but sales fell by 1.3% year on year to $200.4 million. The com…
Pharma Direct and Subscription Revenue Increased 76% and 39%, Respectively, Year-Over-Year Company Raises Full-Year 2026 Revenue and Adjusted EBITDA Expectations SANTA MONICA, Calif., August 05, 2026--(BUSINESS WIRE)--GoodRx Holdings, Inc.…
Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring…
Labcorp Holdings LH shares soared 3.4% in the last trading session to close at $291.02. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.1% gain over the past…
1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to…
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings? GoodRx has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13.1%. The stock now trades at $3.14, marking a 21.5% gain. This was partly thanks to it…
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it wil…
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's Check out the companies making headlines yesterday: RXO (NYSE:RXO): Freight Delivery Company RXO (NYSE:RXO) rose by 4.2% on Monday after Stifel raised its price t…
GoodRx (GDRX) Stock Trades Up, Here Is Why What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 2.6% in the afternoon session after the company announced a partnership with Paytient, a healthcare affordability solut…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. GoodRx Holdings (GDRX) continues to attract attention as investors weigh its recent share price moves, with the stock closin…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. GoodRx Holdings stock has seen a steep share price decline over the past few years, yet on curren…
SANTA MONICA, Calif., July 09, 2026--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 fina…
1 Mooning Stock to Target This Week and 2 That Underwhelm Great things are happening to the stocks in this article. They're all outperforming the market over the last month because of positive catalysts such as a new product line, construc…
GoodRx Holdings, Inc. (GDRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered th…
Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a…
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly l…